» Articles » PMID: 31384076

Patent Pooling to Increase Access to Essential Medicines

Overview
Specialty Public Health
Date 2019 Aug 7
PMID 31384076
Citations 18
Authors
Affiliations
Soon will be listed here.
Citing Articles

: visions for the future.

Piggott T, Moja L, Huttner B, Okwen P, Raviglione M, Kredo T Bull World Health Organ. 2024; 102(10):722-729.

PMID: 39318894 PMC: 11418853. DOI: 10.2471/BLT.24.292359.


Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and response.

Braimoh T, Burrone E, Gore C, Vijayaraghavan P Global Health. 2024; 20(1):52.

PMID: 38956614 PMC: 11221111. DOI: 10.1186/s12992-024-01057-5.


Novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries.

Malhotra S, Cameron A, Gotham D, Burrone E, Gardner P, Loynachan C PLOS Glob Public Health. 2024; 4(7):e0003418.

PMID: 38950021 PMC: 11216602. DOI: 10.1371/journal.pgph.0003418.


Ground-breaking change to the mental health section of the WHO Model List of Essential Medicines: implications for low- and middle-income countries.

Barbui C, Papola D, Todesco B, Gastaldon C, Ostuzzi G Epidemiol Psychiatr Sci. 2024; 33:e3.

PMID: 38297463 PMC: 10894702. DOI: 10.1017/S2045796024000040.


Negotiating public-health intellectual property licensing agreements to increase access to health technologies: an insider's story.

Gore C, Morin S, Rottingen J, Kieny M BMJ Glob Health. 2023; 8(9).

PMID: 37669799 PMC: 10496684. DOI: 10.1136/bmjgh-2023-012964.


References
1.
Magrini N, Robertson J, Forte G, Cappello B, Moja L, de Joncheere K . Tough decisions on essential medicines in 2015. Bull World Health Organ. 2015; 93(4):283-4. PMC: 4431566. DOI: 10.2471/BLT.15.154385. View

2.
Wirtz V, Hogerzeil H, Gray A, Bigdeli M, de Joncheere C, Ewen M . Essential medicines for universal health coverage. Lancet. 2016; 389(10067):403-476. PMC: 7159295. DOI: 10.1016/S0140-6736(16)31599-9. View